Comparison of the functional properties of three different truncated thyroid hormone receptors identified in subjects with resistance to thyroid hormone

Molecular and Cellular Endocrinology

Volumn 137, Issue 2, 1998, Pages 169-176

  Miyoshi, Yoji ^a   Nakamura, Hirotoshi ^b   Tagami, Tetsuya ^a   Sasaki, Shigekazu ^a   Dorin, Richard I ^c   Taniyama, Matsuo ^d   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c VA Medical Center   (United States)

^d SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dominant negative effect; Resistance to thyroid hormone; Silencing activity; Thyroid hormone receptor; Truncated receptor

Indexed keywords

LIOTHYRONINE; MUTANT PROTEIN; RETINOID X RECEPTOR; THYROID HORMONE RECEPTOR;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CELL STRAIN COS1; CENTRAL NERVOUS SYSTEM; DNA BINDING; FEMALE; GENE MUTATION; GENETIC TRANSCRIPTION; HEREDITY; HORMONE BINDING; HUMAN; HUMAN CELL; MALE; MENTAL DEFICIENCY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DOMAIN; SILENT GENE; THYROID HORMONE RESISTANCE; TRANSACTIVATION;

ADOLESCENT; ADULT; ANIMALS; BASE SEQUENCE; CHILD; COS CELLS; DIMERIZATION; DNA; DNA PROBES; DRUG RESISTANCE; FEMALE; GOITER; HUMANS; MALE; MENTAL RETARDATION; RECEPTORS, THYROID HORMONE; RECOMBINANT PROTEINS; SEQUENCE DELETION; THYROID HORMONE RESISTANCE SYNDROME; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TRETINOIN; TRIIODOTHYRONINE;

EID: 0032574310     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(97)00244-X     Document Type: Article

References (31)

1. Adams M., Matthews C., Collingwood T.N., Tone Y., Beck-peccoz P., Chatterjee V.K.K. Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor β gene. J. Clin. Invest. 94:1994;506-515.
2. Baniahmad A., Ha I., Reinberg D., Tsai S., Tsai M-j., O'Malley B.W. Interaction of human thyroid hormone receptor β with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone. Proc. Natl. Acad. Sci. USA. 90:1993;8832-8836.
3. Baniahmad A., Leng X., Brris T.P., Tsai S.Y., Tsai M-j., O'Malley B.W. The τ4 activation domain of the thyroid receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol. Cell. Biol. 15:1995;76-86.
4. Casanova J., Heimer E., Selmi-Ruby S., Qi J-S., Au-Fliegner M., Desai-Yajnik V., Koudinova N., Yarm F., Raaka B.M., Samuels H.H. Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor. Mol. Cell. Biol. 14:1994;5756-5765.
5. Chatterjee V.K.K., Nagaya T., Madison L.D., Datta S., Rentoumis A., Jameson J.L. Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors. J. Clin. Invest. 87:1991;1977-1984.
6. Chen J.D., Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature. 377:1995;454-457.
7. Danielian P.S., White R., Lees J.A., Parker M.G. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11:1992;1025-1033.
8. Fondell J.D., Roy A.L., Roeder R.G. Unliganded thyroid hormone receptor inhibits formation of a functional preinitiation complex: implications for active repression. Genes Dev. 7:1993;1400-1410.
9. Geffner M.E., Su N.F., Ross S., Hershman J.M., Van Dop C., Menke J.B., Hao E., Stanzak R.K., Eaton T., Samuels H.H., Usala S.J. An arginine to histidine in codon 311 of the c-erbAβ gene results in a mutant thyroid hormone receptor that does not mediate a dominant negative phenotype. J. Clin. Invest. 91:1993;538-546.
10. Glass C.K., Lipkin S.M., Devary O.V., Rosenfeld M.G. Positive and negative regulation of gene transcription by a retinoic acid-thyroid hormone receptor heterodimer. Cell. 59:1989;697-708.
11. Graupner G., Wills K.N., Tzukerman M., Zhang X-k., Pfahl P. Dual regulatory role for thyroid-hormone receptors allows control of retinoic-acid receptor activity. Nature. 340:1989;653-656.
12. Groenhout E.G., Dorin R.I. Generalized thyroid hormone resistance due to a deletion of the carboxy terminus of the c-erbAβ receptor. Mol. Cell. Endocrinol. 99:1994;81-88.
13. Horlein A.J., Naar A.M., Heinzel T., Torchia J., Gloss B., Kurokawa R., Ryan A., Kamei Y., Soderstrom M., Glass C.K., Rosenfeld M.G. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature. 377:1995;397-404.
14. Kurokawa R., Soderstrom M., Horlein A., Halachmi S., Brown M., Rosenfeld M.G., Glass C.K. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature. 377:1995;451-454.
15. Lee J.W., Ryan F., Swaffield J.C., Johnston S.A., Moore D.D. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature. 374:1995;91-94.
16. Miyoshi Y., Nakamura H., Tagami T., Sasaki S., Nakao K. 3, 5, 3′-triiodothyronine stimulates retinoic acid-induced differentiation in HL-60 cells. Mol. Cell. Endocrinol. 103:1994;119-123.
17. Miyoshi Y., Nakamura H., Sasaki S., Tagami T., Misaki T., Konishi J., Nakao K. Two consecutive nuceotide substitutions of the T3 receptor β gene resulting in an 11-amino acid truncation in a patient with generalized resistance to thyroid hormone. Mol. Cell. Endocrinol. 114:1995;9-17.
18. Nakamura, H., Miyoshi, Y., Sasaki, S., Tagami, T., Nakao, K., Taniyama, M., Yoshimi, T., 1994. Comparison among three truncated T3 receptors identified in patients with generalized resistance to thyroid hormone (GRTH). Program of the 68th Annual Meeting of The American Thyroid Association, Chicago, Illinois (Abstract S-73).
19. Refetoff S., Weiss R.E., Usala S.J. The syndromes of resistance to thyroid hormone. Endocr. Rev. 14:1993;348-399.
20. RTH workshop, 1994. Proceedings of the First Workshop on RTH, July 10-11, 1993, Cambridge, United Kingdom. J. Clin. Endocrinol. Metab. 78, 990-993.
21. Parrilla R., Mixson A.J., McPherson J.A., McClaskey J.H., Weintraub B.D. Characterization of seven novel mutations of the c-erbAb gene in unrelated kindreds with generalized thyroid hormone resistance. J. Clin. Invest. 88:1991;2123-2130.
22. Saatcioglu F., Bartunek P., Deng T., Zenke M., Karin M. A conserved C-terminal sequence that is deleted in v-erbA is essential for the biological activities of c-erbA (the thyroid hormone receptor). Mol. Cell. Biol. 13:1993;3675-3685.
23. Samuels H.H., Stanly F., Casanova J. Deletion of L-3, 5, 3′-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology. 105:1979;80-85.
24. Sasaki S., Nakamura H., Tagami T., Miyoshi Y., Nogimori T., Mitsuma T., Imura H. Pituitary resistance to thyroid hormone associated with a base mutation in the hormone-binding domain of the human 3, 5, 3′-triiodothyronine receptor-β J. Clin. Endocrinol. Metab. 76:1993;1254-1258.
25. Seol W., Choi H-S., Moore D.D. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol. Endocrinol. 9:1995;72-85.
26. Sharif M., Privalsky M.L. v-erbA oncogene function in neoplasia correlates with its ability to repress retinoic acid receptor action. Cell. 66:1991;885-893.
27. Takeda K., Balzano S., Sakurai A., DeGroot L.J., Refetoff S. Screening of nineteen unrelated families with generalized resistance to thyroid hormone receptor β gene and the detection of a new mutation. J. Clin. Invest. 87:1991;496-502.
28. Taniyama M., Kusano S., Miyoshi Y., Nakamura H., Kaihara M., Tobe T., Tomita M., Katagiri T., Ban Y. Mild resistance to thyroid hormone with a truncated thyroid hormone receptor β Exp. Clin. Endocrinol. Diabetes. 104:1996;339-343.
29. Umesono K., Murakami K.K., Thompson C.C., Evans R.M. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell. 65:1991;1255-1266.
30. Yoh S.M., Chatterjee V.K.K., Privalsky M.L. Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors. Mol. Endocrinol. 11:1997;470-480.
31. Zenke M., Munoz A., Sap J., Venstrom B., Berg H. v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. Cell. 61:1990;1035-1049.